These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
388 related items for PubMed ID: 23774604
1. Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain. Skyberg JA, Rollins MF, Samuel JW, Sutherland MD, Belisle JT, Pascual DW. Infect Immun; 2013 Sep; 81(9):3099-105. PubMed ID: 23774604 [Abstract] [Full Text] [Related]
2. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. KuoLee R, Harris G, Conlan JW, Chen W. Vaccine; 2007 May 10; 25(19):3781-91. PubMed ID: 17346863 [Abstract] [Full Text] [Related]
3. Identification of a live attenuated vaccine candidate for tularemia prophylaxis. Mahawar M, Rabadi SM, Banik S, Catlett SV, Metzger DW, Malik M, Bakshi CS. PLoS One; 2013 May 10; 8(4):e61539. PubMed ID: 23613871 [Abstract] [Full Text] [Related]
4. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism. Wayne Conlan J, Shen H, Kuolee R, Zhao X, Chen W. Vaccine; 2005 Mar 31; 23(19):2477-85. PubMed ID: 15752834 [Abstract] [Full Text] [Related]
5. An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy. Golovliov I, Lindgren H, Eneslätt K, Conlan W, Mosnier A, Henry T, Sjöstedt A. Front Cell Infect Microbiol; 2016 Mar 31; 6():152. PubMed ID: 27933275 [Abstract] [Full Text] [Related]
6. Francisella tularensis Live Vaccine Strain training of murine alveolar and bone marrow-derived macrophages. Khan H, Bhargava V, Elkins KL. Microbiol Spectr; 2024 Aug 06; 12(8):e0002824. PubMed ID: 38940590 [Abstract] [Full Text] [Related]
9. Francisella tularensis live vaccine strain folate metabolism and pseudouridine synthase gene mutants modulate macrophage caspase-1 activation. Ulland TK, Janowski AM, Buchan BW, Faron M, Cassel SL, Jones BD, Sutterwala FS. Infect Immun; 2013 Jan 06; 81(1):201-8. PubMed ID: 23115038 [Abstract] [Full Text] [Related]
10. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp. tularensis. Jia Q, Horwitz MA. Front Cell Infect Microbiol; 2018 Jan 06; 8():154. PubMed ID: 29868510 [Abstract] [Full Text] [Related]
11. IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection. Roberts LM, Davies JS, Sempowski GD, Frelinger JA. Vaccine; 2014 Jun 17; 32(29):3595-603. PubMed ID: 24837506 [Abstract] [Full Text] [Related]
12. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge. Jia Q, Lee BY, Bowen R, Dillon BJ, Som SM, Horwitz MA. Infect Immun; 2010 Oct 17; 78(10):4341-55. PubMed ID: 20643859 [Abstract] [Full Text] [Related]
13. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion. Baron SD, Singh R, Metzger DW. Infect Immun; 2007 May 17; 75(5):2152-62. PubMed ID: 17296747 [Abstract] [Full Text] [Related]
14. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain. Bakshi CS, Malik M, Mahawar M, Kirimanjeswara GS, Hazlett KR, Palmer LE, Furie MB, Singh R, Melendez JA, Sellati TJ, Metzger DW. Vaccine; 2008 Sep 26; 26(41):5276-88. PubMed ID: 18692537 [Abstract] [Full Text] [Related]
15. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge. Jia Q, Bowen R, Sahakian J, Dillon BJ, Horwitz MA. Infect Immun; 2013 May 26; 81(5):1550-61. PubMed ID: 23439306 [Abstract] [Full Text] [Related]
16. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia. Golovliov I, Twine SM, Shen H, Sjostedt A, Conlan W. PLoS One; 2013 May 26; 8(11):e78671. PubMed ID: 24236032 [Abstract] [Full Text] [Related]
17. Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs. Anderson RV, Crane DD, Bosio CM. Vaccine; 2010 Sep 14; 28(40):6562-72. PubMed ID: 20688042 [Abstract] [Full Text] [Related]
18. Differing effects of interleukin-10 on cutaneous and pulmonary Francisella tularensis live vaccine strain infection. Metzger DW, Salmon SL, Kirimanjeswara G. Infect Immun; 2013 Jun 14; 81(6):2022-7. PubMed ID: 23529615 [Abstract] [Full Text] [Related]
19. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia. Hickey AJ, Hazlett KR, Kirimanjeswara GS, Metzger DW. Vaccine; 2011 Sep 16; 29(40):6941-7. PubMed ID: 21803089 [Abstract] [Full Text] [Related]
20. Lung CD4-CD8- double-negative T cells are prominent producers of IL-17A and IFN-gamma during primary respiratory murine infection with Francisella tularensis live vaccine strain. Cowley SC, Meierovics AI, Frelinger JA, Iwakura Y, Elkins KL. J Immunol; 2010 May 15; 184(10):5791-801. PubMed ID: 20393138 [Abstract] [Full Text] [Related] Page: [Next] [New Search]